The clinical and genomic significance of donor-specific antibody-positive/C4d-negative and donor-specific antibody-negative/C4d-negative transplant glomerulopathy

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 12, 2013, Pages 2141-2148

  Hayde, Nicole ^a   Bao, Yi ^b   Pullman, James ^c   Ye, Bin ^c   Brent Calder, R ^c   Chung, Monica ^c   Schwartz, Daniel ^c   Lubetzky, Michelle ^b,d   Ajaimy, Maria ^b,d   de Boccardo, Graciela ^b,d   Akalin, Enver ^b,d  

^a Division of Nephrology   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c Department of Pathology ^*  (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C4D; CYCLOSPORIN A; GAMMA INTERFERON; HLA ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; ALLOANTIBODY; COMPLEMENT C4D; COMPLEMENT COMPONENT C4B; PEPTIDE FRAGMENT;

ADULT; ANTIBODY MEDIATED REJECTION; ARTICLE; ATROPHY; CAPILLARITIS; ELECTRON MICROSCOPY; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; GENE EXPRESSION; GLOMERULITIS; GLOMERULOPATHY; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PROTEIN MICROARRAY; ALLOGRAFT; BIOPSY; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DNA MICROARRAY; ENDOTHELIUM CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GENOMICS; GLOMERULONEPHRITIS; GRAFT REJECTION; HISTOCOMPATIBILITY; HUMORAL IMMUNITY; IMMUNOLOGY; KAPLAN MEIER METHOD; KIDNEY TRANSPLANTATION; MICROVASCULATURE; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; RISK FACTOR; TIME;

ADULT; ALLOGRAFTS; BIOPSY; COMPLEMENT C4B; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOMICS; GLOMERULONEPHRITIS; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; ISOANTIBODIES; KAPLAN-MEIER ESTIMATE; KIDNEY TRANSPLANTATION; MALE; MICROVESSELS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS;

EID: 84889838399     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04240413     Document Type: Article

References (31)

1. Racusen LC, Colvin RB, Solez K, Mihatsch MJ, Halloran PF, Campbell PM, Cecka MJ, Cosyns JP, Demetris AJ, Fishbein MC, Fogo A, Furness P, Gibson IW, Glotz D, Hayry P, Hunsickern L, Kashgarian M, Kerman R, Magil AJ, Montgomery R, Morozumi K, Nickeleit V, Randhawa P, Regele H, Seron D, Seshan S, Sund S, Trpkov K: Antibody-mediated rejection criteria-an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 3: 708-714, 2003
2. Sis B: Endothelial molecules decipher the mechanisms and functional pathways in antibody-mediated rejection. Hum Immunol 73: 1218-1225, 2012
3. Sis B, Jhangri GS, Riopel J, Chang J, de Freitas DG, Hidalgo L, Mengel M, Matas A, Halloran PF: A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. Am J Transplant 12: 1168-1179, 2012
4. Mengel M, Sis B, Haas M, Colvin RB, Halloran PF, Racusen LC, Solez K, Cendales L, Demetris AJ, Drachenberg CB, Farver CF, Rodriguez ER, Wallace WD, Glotz D; Banff meeting report writing committee: Banff 2011 Meeting report: New concepts in antibody-mediated rejection. Am J Transplant 12: 563-570, 2012
5. Sis B, Campbell PM, Mueller T, Hunter C, Cockfield SM, Cruz J, Meng C, Wishart D, Solez K, Halloran PF: Transplant glomerulopathy, late antibody-mediated rejection and the ABCDtetrad in kidney allograft biopsies for cause. Am J Transplant 7: 1743-1752, 2007
6. Haas M, Mirocha J: Early ultrastructural changes in renal allografts: Correlation with antibody-mediated rejection and transplant glomerulopathy. Am J Transplant 11: 2123-2131, 2011
7. Loupy A, Suberbielle-Boissel C, Hill GS, Lefaucheur C, Anglicheau D, Zuber J, Martinez F, Thervet E, Méjean A, Charron D, Duong van Huyen JP, Bruneval P, Legendre C, Nochy D: Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant 9: 2561-2570, 2009
8. Gloor JM, Sethi S, Stegall MD, Park WD, Moore SB, DeGoey S, Griffin MD, Larson TS, Cosio FG: Transplant glomerulopathy: Subclinical incidence and association with alloantibody. Am J Transplant 7: 2124-2132, 2007
9. Akalin E, Dinavahi R, Dikman S, de Boccardo G, Friedlander R, Schroppel B, Sehgal V, Bromberg JS, Heeger P, Murphy B: Transplant glomerulopathy may occur in the absence of donorspecific antibody and C4d staining. Clin J Am Soc Nephrol 2: 1261-1267, 2007
10. Akalin E, Dikman S, Murphy B, Bromberg JS, Hancock WW: Glomerular infiltration by CXCR3+ ICOS+ activated T cells in chronic allograft nephropathy with transplant glomerulopathy. Am J Transplant 3: 1116-1120, 2003
11. Homs S, Mansour H, Desvaux D, Diet C, Hazan M, Buchler M, Lebranchu Y, Buob D, Badoual C, Matignon M, Audard V, Lang P, Grimbert P: Predominant Th1 and cytotoxic phenotype in biopsies from renal transplant recipients with transplant glomerulopathy. Am J Transplant 9: 1230-1236, 2009
12. De Serres SA, Vadivel N, Mfarrej BG, Grafals M, DeJoseph M, Dyer C, Magee CN, Chandraker A, Gallon LG, Najafian N: Monocyte-secreted inflammatory cytokines are associated with transplant glomerulopathy in renal allograft recipients. Transplantation 91: 552-559, 2011
13. Elster EA, Hawksworth JS, Cheng O, Leeser DB, Ring M, Tadaki DK, Kleiner DE, Eberhardt JS 3rd, Brown TS, Mannon RB: Probabilistic (Bayesian) modeling of gene expression in transplant glomerulopathy. J Mol Diagn 12: 653-663, 2010
14. Sun Q, Zhang M, Xie K, Li X, Zeng C, Zhou M, Liu Z: Endothelial injury in transplant glomerulopathy is correlated with transcription factor T-bet expression. Kidney Int 82: 321-329, 2012
15. Baid-Agrawal S, Farris AB 3rd, Pascual M, Mauiyyedi S, Farrell ML, Tolkoff-Rubin N, Collins AB, Frei U, Colvin RB: Overlapping pathways to transplant glomerulopathy: Chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy. Kidney Int 80: 879-885, 2011
16. Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, Halloran PF, Baldwin W, Banfi G, Collins AB, Cosio F, David DS, Drachenberg C, Einecke G, Fogo AB, Gibson IW, Glotz D, Iskandar SS, Kraus E, Lerut E, Mannon RB, Mihatsch M, Nankivell BJ, Nickeleit V, Papadimitriou JC, Randhawa P, Regele H, Renaudin K, Roberts I, Seron D, Smith RN, Valente M: Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 8: 753-760, 2008
17. Sis B, Mengel M, Haas M, Colvin RB, Halloran PF, Racusen LC, Solez K, Baldwin WM 3rd, Bracamonte ER, Broecker V, Cosio F, Demetris AJ, Drachenberg C, Einecke G, Gloor J, Glotz D, Kraus E, Legendre C, Liapis H, Mannon RB, Nankivell BJ, Nickeleit V, Papadimitriou JC, Randhawa P, Regele H, Renaudin K, Rodriguez ER, Seron D, Seshan S, Suthanthiran M, Wasowska BA, Zachary A, Zeevi A: Banff'09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 10: 464-471, 2010
18. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Yamaguchi Y, et al: The Banff 97 working classification of renal allograft pathology. Kidney Int 55: 713-723, 1999
19. Gibson IW, Gwinner W, Bröcker V, Sis B, Riopel J, Roberts IS, Scheffner I, Jhangri GS, Mengel M: Peritubular capillaritis in renal allografts: Prevalence, scoring system, reproducibility and clinicopathological correlates. Am J Transplant 8: 819-825, 2008
20. Marfo K, Ling M, Bao Y, Calder B, Ye B, Hayde N, Greenstein S, Chapochnick-Friedman J, Glicklich D, de Boccardo G, Kinkhabwala M, Akalin E: Lack of effect in desensitization with intravenous immunoglobulin and rituximab in highly sensitized patients. Transplantation 94: 345-351, 2012
21. Hayde N, Bao Y, Pullman J, Ye B, Calder BR, Chung M, Schwartz D, Alansari A, de Boccardo G, Ling M, Akalin E: The clinical and molecular significance of C4d staining patterns in renal allografts. Transplantation 95: 580-588, 2013
22. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550, 2005
23. Colvin RB: Antibody-mediated renal allograft rejection: Diagnosis and pathogenesis. J Am Soc Nephrol 18: 1046-1056, 2007
24. Sis B, Jhangri GS, Bunnag S, Allanach K, Kaplan B, Halloran PF: Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 9: 2312-2323, 2009
25. Hidalgo LG, Sis B, Sellares J, Campbell PM, Mengel M, Einecke G, Chang J, Halloran PF: NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: Evidence for NK cell involvement in antibody-mediated rejection. Am J Transplant 10: 1812-1822, 2010
26. Mueller TF, Einecke G, Reeve J, Sis B, Mengel M, Jhangri GS, Bunnag S, Cruz J, Wishart D, Meng C, Broderick G, Kaplan B, Halloran PF: Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant 7: 2712-2722, 2007
27. Batal I, Lunz JG 3rd, Aggarwal N, Zeevi A, Sasatomi E, Basu A, Tan H, Shapiro R, Randhawa P: A critical appraisal of methods to grade transplant glomerulitis in renal allograft biopsies. Am J Transplant 10: 2442-2452, 2010
28. Batal I, Azzi J, El-Haddad N, Riella LV, Lunz JG 3rd, Zeevi A, Sasatomi E, Basu A, Tan H, Shapiro R, Randhawa P: Immunohistochemicalmarkers of tissue injury in biopsies with transplant glomerulitis. Hum Pathol 43: 69-80, 2012
29. Loupy A, Hill GS, Suberbielle C, Charron D, Anglicheau D, Zuber J, Timsit MO, Duong JP, Bruneval P, Vernerey D, Empana JP, Jouven X, Nochy D, Legendre CH: Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA).AmJ Transplant 11: 56-65, 2011
30. Hidalgo LG, Sellares J, Sis B, Mengel M, Chang J, Halloran PF: Interpreting NK cell transcripts versus T cell transcripts in renal transplant biopsies. Am J Transplant 12: 1180-1191, 2012
31. Dean PG, Park WD, Cornell LD, Gloor JM, Stegall MD: Intragraft gene expression in positive crossmatch kidney allografts: Ongoing inflammation mediates chronic antibody-mediated injury. Am J Transplant 12: 1551-1563, 2012